We are Plasma Med Research, now doing business as "Xera Med" as we launch outside of simply blood and plasma-based clinical studies take on Phase 0, II-IV drug and diagnostics trials. Ultimately, we serve as the necessary starting point -- the seed -- required for researchers to cultivate better treatments and more accurate diagnostics.